Mayfair Advisory Group, LLC Baxter International Inc Transaction History

Mayfair Advisory Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$49.7 - $57.71 $12,872 - $14,946	259 Added 5.77%	4,751 $0
Q3 2022 Nov 08, 2022	SELL	$53.86 - $66.8 $62,854 - $77,955	-1,167 Reduced 20.62%	4,492 $250,000
Q2 2022 Aug 09, 2022	BUY	$63.83 - $80.0 $122,362 - $153,360	1,917 Added 51.23%	5,659 $332,000
Q1 2022 Apr 14, 2022	BUY	$76.85 - $89.45 $23,285 - $27,103	303 Added 8.81%	3,742 $294,000
Q4 2021 Jan 19, 2022	BUY	$74.57 - $87.19 $37,881 - $44,292	508 Added 17.33%	3,439 $302,000
Q3 2021 Oct 08, 2021	BUY	$73.77 - $83.61 $22,868 - $25,919	310 Added 11.83%	2,931 $236,000
Q2 2021 Jul 29, 2021	BUY	$80.5 - $88.01 $210,990 - $230,674	2,621 New	2,621 $211,000

1,007

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Mayfair Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Mayfair Advisory Group, LLC with notifications on news.